Medical comorbidities in bipolar disorder (BIPCOM): clinical validation of risk factors and biomarkers to improve prevention and treatment. Study protocol.

MLA

de Girolamo, Giovanni, et al. “Medical Comorbidities in Bipolar Disorder (BIPCOM): Clinical Validation of Risk Factors and Biomarkers to Improve Prevention and Treatment. Study Protocol.” International Journal of Bipolar Disorders, vol. 12, no. 1, May 2024, p. 15. EBSCOhost, https://doi.org/10.1186/s40345-024-00337-8.

APA

de Girolamo, G., Andreassen, O. A., Bauer, M., Brambilla, P., Calza, S., Citerà, N., Corcoy, R., Fagiolini, A., Garcia-Argibay, M., Godin, O., Klingler, F., Kobayashi, N. F., Larsson, H., Leboyer, M., Matura, S., Martinelli, A., De la Peña-Arteaga, V., Poli, R., Reif, A., … Caselani, E. (2024). Medical comorbidities in bipolar disorder (BIPCOM): clinical validation of risk factors and biomarkers to improve prevention and treatment. Study protocol. International Journal of Bipolar Disorders, 12(1), 15. https://doi.org/10.1186/s40345-024-00337-8

Chicago

de Girolamo, Giovanni, Ole A Andreassen, Michael Bauer, Paolo Brambilla, Stefano Calza, Nicholas Citerà, Rosa Corcoy, et al. 2024. “Medical Comorbidities in Bipolar Disorder (BIPCOM): Clinical Validation of Risk Factors and Biomarkers to Improve Prevention and Treatment. Study Protocol.” International Journal of Bipolar Disorders 12 (1): 15. doi:10.1186/s40345-024-00337-8.